The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

Conditions:   Influenza A Virus Infection;   Influenza A;   Influenza Epidemic;   Influenza H5N1 Intervention:   Biological: GamFluVac Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials